

"Wearable bioelectronic devices that stimulate blood flow to prevent clots and heal chronic wounds"
Firstkind develops the geko device, a knee-worn medical device that uses neuromuscular electrostimulation to activate muscle pumps and increase blood circulation. The technology addresses three clinical challenges: preventing venous thromboembolism in acute stroke and post-operative patients, accelerating chronic wound healing, and managing trauma related oedema. The company partners with NHS hospital trusts and universities in multi-centre randomised controlled trials. Evidence shows the device doubles wound healing rates in venous leg ulcers and reduces VTE risk in immobile patients, offering clinicians a non-invasive alternative to compression and pharmacological interventions.


39
Team Members
2010
Founded
Medical Devices
Sector
Hybrid
Work Environment
A world where preventable blood clots, chronic wounds, and post-surgical complications no longer limit recovery or threaten lives in hospital and community care.
Firstkind delivers bioelectronic neuromuscular electrostimulation devices that increase blood circulation to prevent venous thromboembolism, accelerate chronic wound healing, and manage oedema in acute and community clinical settings.